(VHT) Vanguard Health Care Shares - Ratings and Ratios
Pharmaceuticals, Biotechnology, Healthcare Equipment, Managed Care, Life Sciences
Description: VHT Vanguard Health Care Shares October 30, 2025
The Vanguard Health Care Index Fund ETF (VHT) follows a pure indexing strategy that seeks to mirror the performance of its benchmark-a GICS-defined U.S. health-care index comprising large, mid-size, and small-cap stocks. The fund attempts to hold each constituent in roughly the same proportion as the index, investing essentially all of its assets in those securities.
Key metrics as of the latest filing: an expense ratio of 0.10 %, total assets of roughly $10 billion, and a 12-month trailing return of about +9 % (subject to market conditions). The health-care sector is driven by demographic aging (U.S. population 65+ projected to reach 21 % by 2030), sustained R&D spending (biotech R&D intensity averaging 12 % of revenue), and policy factors such as Medicare reimbursement rates. VHT’s top holdings typically include major players like UnitedHealth Group, Johnson & Johnson, and Pfizer, which together account for roughly 30 % of the fund’s net assets.
For a deeper, data-rich analysis of VHT’s risk-adjusted performance and sector exposure, you might explore the ValueRay platform to compare it against peer ETFs and identify any hidden valuation edges.
VHT ETF Overview
| Market Cap in USD | 16,280m |
| Category | Health |
| TER | 0.10% |
| IPO / Inception | 2004-01-26 |
VHT ETF Ratings
| Growth Rating | 22.5% |
| Fundamental | - |
| Dividend Rating | 56.5% |
| Return 12m vs S&P 500 | -16.2% |
| Analyst Rating | - |
VHT Dividends
| Dividend Yield 12m | 1.44% |
| Yield on Cost 5y | 2.08% |
| Annual Growth 5y | 9.28% |
| Payout Consistency | 96.0% |
| Payout Ratio | % |
VHT Growth Ratios
| Growth Correlation 3m | 90.6% |
| Growth Correlation 12m | -23.4% |
| Growth Correlation 5y | 73.4% |
| CAGR 5y | 5.78% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.34 |
| CAGR/Mean DD 3y (Pain Ratio) | 1.07 |
| Sharpe Ratio 12m | 0.84 |
| Alpha | -14.28 |
| Beta | 0.740 |
| Volatility | 12.20% |
| Current Volume | 177.7k |
| Average Volume 20d | 176.7k |
| Stop Loss | 262.2 (-3%) |
| Signal | 0.89 |
What is the price of VHT shares?
Over the past week, the price has changed by -0.83%, over one month by +4.15%, over three months by +12.44% and over the past year by +1.79%.
Is Vanguard Health Care Shares a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of VHT is around 253.77 USD . This means that VHT is currently overvalued and has a potential downside of -6.14%.
Is VHT a buy, sell or hold?
What are the forecasts/targets for the VHT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 283.6 | 4.9% |
VHT Fundamental Data Overview October 30, 2025
Beta = 0.74
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 16.28b USD (16.28b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 16.28b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 16.28b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.74% (E(16.28b)/V(16.28b) * Re(8.74%) + (debt-free company))
Discount Rate = 8.74% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for VHT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle